Factors to Consider in the Treatment of Early Relapsed/Refractory Multiple Myeloma

Factors to Consider in the Treatment of Early Relapsed/Refractory Multiple Myeloma
Factors to Consider in the Treatment of Early Relapsed/Refractory Multiple Myeloma
CME, CPE
Sikander Ailawadhi, MD
Release Date: February 07, 2020
Expiration Date: February 07, 2021

Managing a newly diagnosed patient with multiple myeloma can present challenges. In this activity, Dr. Ailawadhi covers the key aspects of treatment for patients living with relapsed or refractory multiple myeloma.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.
Begin, Earn CreditView Only, No CreditGet Certificate